Next-generation sequencing
Next-generation sequencing is a powerful tool that can identify mutations or fusions in a wide range of cancers, enabling physicians to provide targeted therapy to patients and improve outcomes. In this vodcast, Professor Andrew Beggs discusses practical aspects of this technique from the clinical viewpoint.
Developed by:
Springer Healthcare
Register now to watch the video
About the expert contributor
Prof. Andrew Beggs
Prof. Beggs is a Professor of Cancer Genetics & Surgery in the Institute of Cancer and Genomic Sciences, University of Birmingham and Deputy Director of the Birmingham Experimental Cancer Medicine Centre. Read more »
Financial disclosure
This content is intended only for healthcare providers, excluding UK, and was made possible by educational funding provided by Illumina, Inc., and Eli Lilly and Company.
Disclaimer
Any information provided and opinions expressed do not necessarily reflect the views of Springer Medizin GmbH. Springer Medizin GmbH and its employees, agents and subcontractors are not responsible or in any way liable for the currency of the information, for any errors, omissions or inaccuracies, or for any consequences arising therefrom. Inclusion or exclusion of any product does not imply its use is either advocated or rejected. Use of trade names is for product identification only and does not imply endorsement. Please consult the latest prescribing information from the manufacturer before issuing prescriptions for any products mentioned.
